Growing Onglyza Cases May Prove to be a Burden for the Manufacturers

Introduction

A product liability lawsuit was filed in the U.S. District Court for the Southern District of Ohio by the widow of an Ohio man, who claims the use of Onglyza was the reason for the congestive heart failure suffered by her husband before his death.

Onglyza cases are centralized as a part of MDL No. 2809, which is witnessing a steady rise in the number of lawsuits as expected since its establishment in February, in the U.S. District Court for the Eastern District of Kentucky under U.S. District Judge Karen K. Caldwell.

Bristol-Myers Squibb and AstraZeneca are the defendants named in the Onglyza litigation over its alleged link to congestive heart failure and other side effects. Plaintiffs hold them responsible for not providing adequate cardiovascular injury warnings despite having the knowledge.

Comments

NC to Get $150M to Boost Opioid Treatment, Recovery

Categories: Opioids

North Carolina will receive an additional $150 million from Purdue Pharma and the Sackler family as part of a national $7.4 billion settlement related to the opioid…

SRI Gets FDA OK for High-Dose Naloxone Trial

Categories: Opioids

SRI has received authorization from the U.S. Food and Drug Administration (FDA) to begin Phase 1 clinical trials of a new, high-dose injectable naloxone formulation.

The approval was granted under an Investigational New Drug (IND)…

Spokane County to Get $5M in New Opioid Settlement

Categories: Opioids

Jurisdictions within Spokane County are set to receive nearly $4.7 million as part of a sweeping $7.4 billion nationwide settlement with Purdue Pharma and its owners, the Sackler family.

The agreement addresses the company’s role in fueling…

Growing Onglyza Cases May Prove to be a Burden for the Manufacturers